References
Editorial (2010) Mechanism matters. Nat Med 16:347
Yaari Y, Seltzer M, Pincus JH (1986) Phenytoin: mechanisms of its anticonvulsant action. Ann Neurol 20:171–184
Goodman LS, Swinyard EA, Toman JE (1946) Studies on the anticonvulsant properties of diphenylhydantoin. Fed Proc 5:180
Putnam TJ, Merritt HH (1937) Experimental determination of the anticonvulsant properties of some phenyl derivatives. Science 85(2213):525–526
Keppel Hesselink JM, Kopsky DJ (2017) Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action. J Neurol. doi:10.1007/s00415-017-8391-5
Williams D (1939) Treatment of epilepsy with sodium diphenyl hydantoinate. Lancet 234(6056):678–681
Frost I (1939) Sodium diphenyl hydantoinate in the treatment of epilepsy: preliminary observations in severe cases. Br J Psychiatry 85:976–985
Victor HG, Drake ME (1940) The effects of intravenous injection of sodium diphenyl hydantoinate (dilantin) on respiration, blood pressure, and the vagus nerve. J Pharmacol Exp Ther 68:36–40
Merritt H Houston, Brenner Charles (1947) Studies in new anticonvulsants. Bull N Y Acad Med 23(5):292
Toman JE (1949) The neuropharmacology of antiepileptics. Electroencephalogr Clin Neurophysiol 1(1):33–44
Pratt CH (1939) Sodium diphenyl hydantoinate (dilantin) and its combination with phenobarbital in the treatment of epilepsy?: a review and preliminary report. BJP 85:986–998
York GK, Steinberg DA (2011) Hughlings Jackson’s neurological ideas. Brain 134:3106–3113
Woodbury DM, Naisbitt MS (1955) Effect of diphenylhydantoin on electrolytes and radiosodium turnover in brain and other tissues of normal, hyponatremic and postictal rats. J Pharmacol Exp Ther 115:74–95
Skou JC (1965) Enzymatic basis for active transport of Na+ and K+ across cell membrane. Physiol Rev 45:596–617
Rawson MD, Pincus JH (1968) The effect of diphenylhydantoin on sodium, potassium, magnesium-activated adenosine triphosphatase in microsomal fractions of rat and guinea pig brain and on whole homogenates of human brain. Biochem Pharmacol 17:573–579
Korey SR (1951) Effect of dilantin and mesantoin on the giant axon of the squid. Proc Soc Exp Biol Med 76:297–299
Hille B (1971) The permeability of the sodium channel to organic cations in myelinated nerve. J Gen Physiol 58(6):599–619
Armstrong CM (1971) Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J Gen Physiol 58(4):413–437
Hille B (2001) Ionic channels of excitable membranes, 3rd edn. Sinauer Associates Inc., Sunderland
Lipicky RJ, Gilbert DL, Stillman IM (1972) Diphenylhydantoin inhibition of sodium conductance in squid giant axon. Proc Natl Acad Sci USA 69(7):1758–1760
Catterall WA (2012) Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol 590(Pt 11):2577–2589
Beneski DA, Catterall WA (1980) Covalent labeling of protein components of the sodium channel with a photoactivable derivative of scorpion toxin. Proc Natl Acad Sci USA 77:639–643
Catterall WA (2000) From Ionic currents to molecular review mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26:13–25
Willow M, Kuenzel EA, Catterall WA (1984) Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol 25(2):228–234
Matsuki N, Quandt FN, Ten Eick RE, Yeh JZ (1984) Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. J Pharmacol Exp Ther 228(2):523–530
Courtney KR, Etter EF (1983) Modulated anticonvulsant block of sodium channels in nerve and muscle. Eur J Pharmacol 88(1):1–9
Qiao X, Sun G, Clare JJ, Werkman TR, Wadman WJ (2014) Properties of human brain sodium channel alpha-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine. Br J Pharmacol 171(4):1054–1067
Terragni B, Scalmani P, Colombo E, Franceschetti S, Mantegazza M (2016) Ranolazine vs phenytoin: greater effect of ranolazine on the transient Na(+) current than on the persistent Na(+) current in central neurons. Neuropharmacology 110(Pt A):223–236
Smith NE, Corry B (2016) Mutant bacterial sodium channels as models for local anesthetic block of eukaryotic proteins. Channels (Austin) 10(3):225–237
Silver K, Soderlund DM (2005) State-dependent block of rat Nav1.4 sodium channels expressed in xenopus oocytes by pyrazoline-type insecticides. Neurotoxicology 26(3):397–406
Nelson M, Yang M, Millican-Slater R, Brackenbury WJ (2015) Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo. Oncotarget 6(32):32914–32929
Boerma RS, Braun KP, van den Broek MP (2016) Remarkable phenytoin sensitivity in 4 children with SCN8A-related epilepsy: a molecular neuropharmacological approach. Neurotherapeutics 13(1):192–197
Black JA, Liu S, Waxman SG (2009) Sodium channel activity modulates multiple functions in microglia. Glia 57(10):1072–1081
Zhao F, Li X, Jin L (2016) Development of a rapid throughput assay for identification of hNav1.7 antagonist using unique efficacious sodium channel agonist, antillatoxin. Mar Drugs 14(2):36
Patejdl R, Leroux AC, Noack T (2015) Phenytoin inhibits contractions of rat gastrointestinal and portal vein smooth muscle by inhibiting calcium entry. Neurogastroenterol Motil 27(10):1453–1465
Chou MY, Lee CY, Liou HH, Pan CY (2014) Phenytoin attenuates the hyper-exciting neurotransmission in cultured embryonic cortical neurons. Neuropharmacology 83:54–61
Deisz RA, Lux HD (1977) Diphenylhydantoin prolongs postsynaptic inhibition and iontophoretic GABA action in the crayfish stretch receptor. Neurosci Lett 5(3–4):199–203
Ayala GF, Lin S, Johnston D (1977) The mechanism of action of diphenylhydantoin or invertebrate neurons. Effects on basic membrane properties. Brain Res 121(2):245–258
Connors BW (1981) A comparison of the effects of pentobarbital and diphenylhydantoin on the GABA sensitivity and excitability of adult sensory ganglion cells. Brain Res 207(2):357–369
Granger P, Biton B, Faure C (1995) Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol Pharmacol 47(6):1189–1196
Kimball OP, Horan TN (1939) The use of Dilantin in the treatment of epilepsy. Ann Intern Med 13:787–793
Shapiro M (1957) Preprinted abstract, annual meeting, Internat Assn for Dental Research. In: Shafer WG (1960) Effect of dilantin sodium on growth of human fibroblast-like cell cultures. Exp Biol Med 104(2):198–201
Shapiro M (1958) Acceleration of gingival wound healing in non-epileptic patients receiving diphenylhydantoin sodium (dilantin, epanutin). Exp Med Surg 16(1):41–53
Bhatia A, Prakash S (2004) Topical phenytoin for wound healing. Dermatol Online 10(1):5
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The author is one of the patent holder of two patents related to topical phenytoin formulations: ‘topical phenytoin for use in the treatment of peripheral neuropathic pain’ and ‘topical pharmaceutical composition containing phenytoin and a (co-)analgesic for the treatment of chronic pain’.
Rights and permissions
About this article
Cite this article
Keppel Hesselink, J.M. Phenytoin: a step by step insight into its multiple mechanisms of action—80 years of mechanistic studies in neuropharmacology. J Neurol 264, 2043–2047 (2017). https://doi.org/10.1007/s00415-017-8465-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-017-8465-4